21.12.2012   

EN

Official Journal of the European Union

C 396/1

1.

Hungary has notified the following additional title of architect (Annex V, point 5.7.1 of Directive 2005/36/EC):

2.

Italy has notified the following additional title of architect (Annex V, point 5.7.1 of Directive 2005/36/EC):

3.

Poland has notified the following additional title of architect (Annex V, point 5.7.1 of Directive 2005/36/EC):

4.

Austria has notified the following additional title of architect (Annex V, point 5.7.1 of Directive 2005/36/EC):

5.

The United Kingdom has notified the following changes to the titles of architect (Annex V, point 5.7.1, to Directive 2005/36/EC):

6.

Spain has notified the following changes to the titles of architect (Annex V, point 5.7.1, to Directive 2005/36/EC):

21.12.2012   

EN

Official Journal of the European Union

C 396/8

1.

Article 168 of the Treaty on the Functioning of the European Union, which states that a high level of human health protection shall be ensured in the definition and implementation of all Union policies and activities. Union action which shall complement national policies shall be directed towards improving public health, preventing illness and disease, and obviating sources of danger to physical and mental health. The Union and Member States shall foster cooperation with third countries and the competent international organisations in the sphere of public health;

2.

The Council Conclusions on Health in all Policies (HiAP) (30 November and 1 December 2006) (1); Healthy and Dignified Ageing (30 November 2009); Equity and health in all policies: Solidarity in Health (8 June 2010); Innovative approaches for chronic diseases in public health and healthcare systems (7 December 2010); Preparatory work for the pilot European Innovation Partnership ‘Active and Healthy Ageing’ (9 March 2011); Closing health gaps within the EU through concerted actions to promote healthy lifestyle behaviors (1 and 2 December 2011) (2);

3.

The Resolution of the WHO Regional Committee for Europe (3): Strategy and action plan on healthy ageing in Europe, 2012-2020;

4.

The Commission Communication dealing with the impact of an ageing population in the EU (2009 ageing report); Europe 2020: A strategy for smart, sustainable and inclusive growth (5 March 2010); Taking forward the Strategic Implementation Plan of the European Innovation Partnership on Active and Healthy Ageing (29 February 2012);

5.

The objectives of EU 2020 Strategy for sustainable, smart and inclusive growth;

6.

The report from the European Cooperation Project Healthy Ageing: Healthy Ageing — A challenge for Europe (2007);

7.

The Commission White Paper Together for health: a strategic approach for the EU 2008-2013, stressing the need to promote good health throughout a person’s lifecycle in an ageing Europe;

8.

The opinion of the European Economic and Social Committee on The impact of population ageing on health and welfare systems (15 July 2010); of the Committee of the Regions on Active Ageing: Innovation-Smart Health-Better life (27 July 2012);

9.

The Council declaration of the European Year for Active Ageing and Solidarity between Generations (2012): The Way Forward.

10.

That healthy ageing is a continuous process across the lifecycle. It is essential to support citizens in this approach through multidisciplinary action in health promotion, disease prevention and in health and social care. This includes work across society and policy areas, involving public authorities and according to MS priorities, stakeholders at all levels, including health professionals and patients, social partners and civil society, the media and economic actors;

11.

That innovative approaches in health promotion and disease prevention could help elderly people to remain independent longer and improve their quality of life.

12.

Good health among working age people contributes to higher productivity and other benefits for citizens and society to meet the goals of EU 2020 Strategy for Smart, Sustainable and Inclusive growth;

13.

The need, with the current economic crisis and the demographic changes, to rethink the structure of services for a more efficient and sustainable healthcare sector fostering a more age-friendly society.

14.

The outcomes of the High Level Conference on Healthy Ageing across the Lifecycle organised by the Cyprus Presidency on 5-6 September 2012, which showcased work in the area of healthy ageing providing evidence that healthy ageing is closely related to the implementation of effective health promotion and disease prevention programmes, starting from the early years of life and continuing throughout the lifecycle;

15.

The promotion of health-enhancing physical activity within the framework of the European Union Work Plan for Sport for 2011-2014 (4) and the principles on the contribution of physical activity to active ageing developed in this context;

16.

The initiative of the European Commission for the launching and implementing the European Innovation Partnership (EIP) on Active and Healthy Ageing and expects the evaluation of this pilot initiative in 2013;

17.

The EU strategies on health determinants and common risk factors including a new EU strategy to support Member States to reduce alcohol related harm;

18.

The Council declaration of the European Year for Active Ageing and Solidarity between Generations (2012): The Way Forward as a booster for future years’ action;

19.

The work towards optimizing the response to the challenges of chronic diseases, building upon the Reflection process launched by the Member States and the Commission (5).

20.

The importance of health promotion, disease prevention and early diagnosis programmes from the early stages of life and throughout the lifecycle;

21.

The far-reaching burden of morbidity and disabilities caused by chronic diseases such as, cancer, respiratory diseases, cardiovascular and neurovascular diseases, diabetes and mental illnesses, musculoskeletal disorders and problems related to hearing and visual impairment in the population;

22.

That better management of long-term health conditions can help people stay active and independent in older age;

23.

That, the public administrations and if appropriate, with the participation of civil society have a crucial role in improving the conditions in relation to healthy ageing;

24.

That economic, social and environmental conditions as well as lifestyles are amongst the determinants of health and addressing them through inter-sectoral action remains one of the important challenges for achieving active and healthy ageing for all.

25.

To make the issue of healthy ageing across the lifecycle, one of their priorities for the coming years, with a social and equity approach;

26.

To adopt an approach that shifts the focus towards health promotion, disease prevention early diagnosis and better condition management from the early years of life and throughout the lifecycle, as a strategy to improve quality of life and reduce the burden of chronic diseases, frailty and disability, through:

27.

To enhance and strengthen coordination and collaboration between all relevant stakeholders and among Member States, promoting intersectoral action, including the civil society, taking into account the health in all policies principle;

28.

To make use of innovative approaches in health promotion and disease prevention, that promote the active involvement of individuals, families and community;

29.

To support the European Innovation Partnership (EIP) on Active and Healthy Ageing by an adhoc involvement of Member States in the implementation of the Partnership's specific actions and in the delivery of robust outcomes, and in advocating and communicating the added value of the Partnership to their regional and local authorities considering the results of the evaluation planned for 2013;

30.

To make effective use of the EU funding, (e.g. structural funds/CSF 2014-2020, FP7/Horizon 2020, CIP) to support priorities on Active and Healthy Ageing;

31.

To support cities and municipalities in their initiative to promote age friendly and healthy environments and to develop networks to implement common guidelines;

32.

To improve communication in health promotion, disease prevention early diagnosis and better condition management through innovative approaches to awareness-raising activities (e.g. responsible use of social media).

33.

To support future actions and initiatives addressing health determinants and risk factors, as well as promoting healthy ageing throughout the lifecycle, at EU, Regional, National and Local level, while respecting the competences of the Member States;

34.

To contribute to the development of policies towards health promoting activities for making healthy choices and living healthy lives;

35.

To support better use by the Member States of the EU Physical Activity Guidelines, welcomed in the Presidency conclusions of the EU Sport Ministers meeting informally in November 2008 (6);

36.

To support Member States voluntary cooperation in view of further developing both general preventive measures as well as selective preventive measures for target group specific needs;

37.

To assist Member States, and specifically regions in more effective use of structural funds and other EU funding instruments for priorities related to healthy ageing.

38.

To properly evaluate the EIP pilot on Active and Healthy Ageing, to allow the participation of interested Member States in the governance of the EIP and to inform Member States of the way the Commission takes into account recommendations of the EIP when implementing EU programmes.

39.

To promote strategies for combating risk factors, such as tobacco use, alcohol related harm, illicit drugs, unhealthy diet and lack of physical activity as well as environmental factors, leading to increased incidence of non-communicable chronic diseases, such as cancer, respiratory diseases, cardiovascular and neurovascular diseases, diabetes, mental illnesses and musculoskeletal disorders;

40.

To support the identification and dissemination of good practice approaches to address chronic diseases and their risk factors, including patient empowerment;

41.

To consider how to strengthen cooperation and improve good practice sharing at European level for promoting healthy ageing lifecycle approach, using innovative tools;

42.

To continue the implementation of the Health Strategy (7) and its objective of the fostering of good health in an ageing Europe while applying a cross-sectoral approach, involving the social and health sectors, with the support of the Working Party on Public Health at Senior Level and in cooperation with the Social Protection Committee;

43.

To continue and strengthen work aimed at better understanding the links between early life events and healthy ageing using inter alia longitudinal studies;

44.

To support, as appropriate, within the framework of the European Health Information System data collection and sharing of data and information on chronic disease incidence, prevalence, risk factors and outcomes, such as healthy life years (HLY) as well as on health promotion policies and actions including information systems within the EU countries, taking into account existing mechanisms and work on-going within the European Statistical System and other relevant stakeholders (such as WHO, WHO Euro and OECD);

45.

To promote the EIP on Active and Healthy Ageing as a relevant multistakeholder collaborative platform built upon consensus and agreement of stakeholders — from public and private sector, NGOs and academia, at EU, national, regional and local levels — committed to delivering on their agreed objectives and goals, according to the results of the evaluation for 2013;

46.

To cooperate with the World Health Organisation (WHO) and in particular with its Regional Office, in order to achieve complementarity in healthy ageing activities.

21.12.2012   

EN

Official Journal of the European Union

C 396/12

—

The Communication from the Commission ‘Action Plan on Organ Donation and Transplantation (2009-2015): Strengthened Cooperation between Member States’ (1), which identified 10 priority actions to help Member States address the three main challenges in the field of organ donation and transplantation, namely: (1) increasing organ availability, (2) enhancing efficiency and accessibility of transplant systems and (3) improving quality and safety.

—

The development of national programmes to improve performance across the different steps of the deceased donation process (from donor identification and maintenance to procurement and transport).

—

The development of a European manual for living donation practices, for kidney and liver transplants.

—

The dissemination of best practices, e.g. through the European manual for setting up and maintaining systems for transplant donor coordination for deceased donation.

—

The planned development of a comprehensive overview of national donor consent systems, as well as the efforts carried out to integrate the participation of intensive care professionals in the deceased donation process.

—

The role of professional societies, such as the European Society for Organ Transplantation (ESOT) and its section, the European Transplant Coordinators Organisation and the European Donation Committee (ETCO-EDC).

—

The efforts undertaken by the Member States in further development of living donation programmes while ensuring a comprehensive protection of the living donor, as discussed at the informal meeting of Ministers of Health on 10-11 July 2012.

—

The organisation of national awareness campaigns and European initiatives, such as the European Organ Donation Days and the Journalists Workshops on Organ Donation and Transplantation organised respectively by the Council of Europe and the European Commission.

—

The development of best practices and training programmes at national and European level supported by the EU Programme of action in the field of health.

—

The importance of encouraging people to commit to becoming organ donors after death.

—

The importance to prioritise donation of organs from deceased donors.

—

The improved quality of life for patients and high cost-effectiveness of kidney transplants compared to dialyses treatments for end-stage renal disease, as analysed for example by authorities in the United Kingdom (Department of Health 2009) or in France (Haute Autorité de Santé, 2010).

—

The lack of medical alternatives for patients in need of life-saving transplants of other organs.

—

That although this is a matter of national competence, there is a need for each Member State to clearly define and organise donor consent systems and to manage waiting lists in a transparent way at national level.

—

The requirement on the Member States to protect living donors against potential risks, physical and financial disadvantages related to the donation process, as well as to ensure voluntary and unpaid donation as laid down in Directive 2010/53/EU.

—

The importance of transparent and comprehensive communication to strengthen public trust in the value of transplant systems based on deceased organ donation as well as on living donations.

—

The need to emphasise the responsibility of intensive care and emergency care professionals and to place donation as part of the decisions to be made in the end of life care.

—

That removal of organs from a living person for transplantation purposes must be carefully scrutinized, case by case, taking in account relevant criteria, in particular the principle that the human body should not be used for financial gain.

1.

To continue sharing expertise on all key aspects of organ donation and transplantation programmes in order to allow for mutual learning and an increase in the number of available organs.

2.

To provide for continuous training of professionals involved in deceased organ donation and transplantation, including both donor transplant coordinators and staff from intensive and emergency care units.

3.

To share information on their national donor consent systems.

4.

To set up comprehensive mechanisms to protect living donors, including the creation of follow-up registers or records, in line with the requirements of Directive 2010/53/EU.

5.

To create transparent and official mechanisms for reimbursing living donors for the costs incurred and, if applicable, for compensating the loss of income in direct relation to the living donation procedure.

6.

To improve awareness amongst patients and their families on the different transplant options, including deceased and living donor transplantation as well as other alternative replacement therapies. To improve information on donation and transplantation in general and to engage healthcare professionals in providing appropriate information on organ donation.

7.

To exchange information on their communication strategies, and to proactively communicate to the general public, including the use of social media.

8.

To develop and improve, as appropriate, programmes for cooperation with intensive care and emergency care professionals, jointly with national and international professional associations, in order to optimize the identification of potential donors and the realisation of the deceased donation process.

—

The establishment and implementation of bilateral or multilateral agreements between Member States to exchange organs and patients that respect the principle of self sufficiency in transplantation, as specified in the Madrid Resolution (2).

—

The setting up of cooperation agreements between national transplant organisations such as the South Transplant Alliance.

—

The sharing of expertise on transplant systems between Member States' competent authorities and with European organ exchange organisations, in particular Eurotransplant and Scandiatransplant.

—

The significant opportunity that exists to treat more patients and to use an increasing number of available organs effectively within the Member States through the conclusion and implementation of bilateral or multilateral agreements between Member States.

—

The need for sufficient administrative capacity within the set-up of national authorities in accordance with Directive 2010/53/EU.

—

That organ trafficking violates fundamental human rights such as those of human dignity and integrity, and has a negative impact on public trust and potential donors willingness to donate organs.

—

That limited knowledge and research of some scientific and organisational aspects of organ transplantation and the lack of the necessary expertise in some areas limit the further development of transplant activities within the EU.

1.

To engage actively in twinning agreements whenever they have less than 10 deceased donors per million inhabitants or when there is a lack of specific transplantation programmes within their borders.

2.

To use community instruments to build up national transplant capacities, where appropriate.

3.

To continue sharing information on the set-up and funding of transplant activities and their oversight.

4.

To engage in operational cross-border exchange of organs, including through the participation in a Joint Action dedicated to cross-border exchange agreements starting in 2013.

5.

To support national and international collaboration, as appropriate, between transplantation authorities and police and customs services in order to detect and prevent organ trafficking.

1.

To include organ transplantation within the scope of EU initiatives against trafficking of human beings (3) in line with recommendations of the World Health Organisation and the Council of Europe.

2.

To address research on technical and organisational aspects of transplantation within the European Research Programme Horizon 2020.

—

That Directive 2010/53/EU sets up minimum standards of quality and safety of human organs intended for transplantation.

—

The need to improve knowledge on health outcomes in transplanted patients in order to further optimize transplant activities taking into account the scarcity of organs.

1.

To share Member States' national procedures for authorisation of procurement organisations and transplantation centres.

2.

To share expertise on the transplantation of organs from expanded criteria donors (for example older donors) in order to increase the number of available organs, while setting the quality and safety limits of such practice.

3.

To engage in collecting and sharing knowledge about quality and safety and in setting up standardised patient follow-up registers or records, based on models commonly developed and agreed upon.

21.12.2012   

EN

Official Journal of the European Union

C 396/15

United Nations — Focal point for delisting

Security Council Subsidiary Organs Branch

Room S-3055 E

New York, NY 10017

UNITED STATES OF AMERICA

Council of the European Union

DG C Coordination Unit

General Secretariat

Rue de la Loi/Wetstraat 175

1048 Bruxelles/Brussel

BELGIQUE/BELGIË

21.12.2012   

EN

Official Journal of the European Union

C 396/16

21.12.2012   

EN

Official Journal of the European Union

C 396/17

(1)

Commission Decision of 30 July 2010 establishing the High Level Forum for a Better Functioning Food Supply Chain (1) is applicable until 31 December 2012.

(2)

The Forum has contributed to competitiveness in the EU agro-food value chain by following the implementation of the recommendations of the High Level Group on the Competitiveness of the Agro-Food Industry and of the initiatives proposed by the Commission in its Communication ‘A Better Functioning Food Supply Chain in Europe’ (2). The Forum has recommended further focussed actions to be carried out. These initiatives need to be followed up. The work of the High Level Forum for a Better Functioning Food Supply Chain should therefore continue after 31 December 2012.

(3)

The membership of the Forum should be extended to national authorities from all Member States to facilitate exchanges of good practice and to enlarge the Forum's outreach. The representation of private organisations should be reviewed on the basis of a public call for application to ensure a balanced representation of stakeholders,

1.

Article 4 is amended as follows:

2.

Article 7 is replaced by the following:

‘Article 7

Applicability

This Decision shall apply until 31 December 2014.’

21.12.2012   

EN

Official Journal of the European Union

C 396/18

21.12.2012   

EN

Official Journal of the European Union

C 396/20

21.12.2012   

EN

Official Journal of the European Union

C 396/21

1.

According to Article 9 of Council Regulation (EC) No 1/2003 of 16 December 2002 on the implementation of the rules on competition laid down in Articles 81 and 82 of the Treaty (1), the Commission may decide — in cases where it intends to adopt a decision requiring that an infringement is brought to an end and the parties concerned offer commitments to meet the concerns expressed to them by the Commission in its preliminary assessment — to make those commitments binding on the undertakings. Such a decision may be adopted for a specified period and shall conclude that there are no longer grounds for action by the Commission. According to Article 27(4) of the same Regulation, the Commission shall publish a concise summary of the case and the main content of the commitments. Interested parties may submit their observations within the time limit fixed by the Commission.

2.

On 19 June 2008, Air Canada (‘AC’), United Airlines (‘UA’), Continental Airlines (‘CO’) and Lufthansa (‘LH’), jointly ‘the parties’, announced their intention to conclude an agreement to form a joint venture covering all their passenger air transport services on transatlantic markets (‘A++ Agreement’). Within the joint venture, AC, UA, CO and LH cooperate on key parameters of competition such as pricing, capacity, schedules and marketing. On 25 July 2008, the Commission opened an ex officio investigation of the cooperation between the parties in A++ Agreement.

3.

On 10 October 2012, the Commission adopted a preliminary assessment within the meaning of Article 9(1) of Regulation (EC) No 1/2003, taking the provisional view that the A++ Joint Venture Agreement between the parties is likely to infringe Article 101 of the Treaty on the Functioning of the European Union.

4.

The Commission considered that in the absence of their cooperation, LH and CO would be actual non-stop competitors on the Frankfurt-New York route, operating their own non-stop flights independently as they did before the implementation of the A++ Agreement.

5.

In the preliminary assessment, the Commission expressed concerns that the cooperation between AC, UA, CO and LH in A++ Agreement would be likely to restrict competition by object on the Frankfurt-New York route with regard to premium passengers.

6.

Considering the parties' combined market position on the Frankfurt-New York route and the closeness of competition between LH and CO, the cooperation would be also likely to produce appreciable anti-competitive effects for premium passengers. The Commission took into consideration the fact that customers on the Frankfurt-New York route are relatively price inelastic and largely deprived of significant buyer power.

7.

The Commission further provisionally concluded that the competition that had existed before the cooperation between LH and CO was eliminated. This competition is unlikely to be replaced by competition from the existing competitors or potential new entrants due to substantial barriers to expansion and entry. These barriers to expansion and entry include slot constraints, hub advantages at both Frankfurt airport and New York JFK and Newark Liberty airports, as well as the frequency advantage of the parties.

8.

Slot constraints are currently present at New York JFK and Newark Liberty airports and are likely to be present in the medium and long run at Frankfurt airport. Due to the hub advantages at Frankfurt and New York airports, the parties are likely to benefit more from economies of scale, brand name recognition, power of their frequent flyer programme (FFP), access to feed traffic and ability to attract corporate contracts than their actual or potential competitors without such hub advantage. Thanks to a higher number of frequencies operated on the Frankfurt-New York route, the parties are likely to have a higher quality of service than their actual or potential competitors, for which the customers are likely to agree to pay higher prices.

9.

The parties subject to the proceedings have offered commitments pursuant to Article 9 of Regulation (EC) No 1/2003, to meet the Commission’s competition concerns. The parties emphasised that this should not be interpreted as an acknowledgement that they have infringed the EU competition rules or that the A++ Agreement is incompatible with Article 101 of the TFEU.

10.

The commitments are briefly summarised below and published in full in English on the website of the Directorate-General for Competition at:

http://ec.europa.eu/competition/index_en.html

11.

The parties offer on the Frankfurt-New York route:

12.

The parties offer to give responsibility to a trustee to monitor the application of the commitments. In case of disagreement between a new entrant and the parties on the commitments, the parties offer a dispute resolution process where an arbitral tribunal will ultimately decide on the matter.

13.

Subject to market testing, the Commission intends to adopt a decision under Article 9(1) of Regulation (EC) No 1/2003 declaring binding the commitments summarised above and published on the Internet, on the website of the Directorate-General for Competition.

14.

In accordance with Article 27(4) of Regulation (EC) No 1/2003, the Commission invites interested third parties to submit their observations on the proposed commitments. These observations must reach the Commission not later than one month following the date of this publication. Interested third parties are also asked to submit a non-confidential version of their comments, in which any information they claim to be business secrets and other confidential information should be deleted and replaced as required by a non-confidential summary or by the words ‘business secrets’ or ‘confidential’.

15.

Answers and comments should preferably be reasoned and should set out the relevant facts. If you identify a problem with any part of the proposed commitments, the Commission would also invite you to suggest a possible solution.

16.

Observations can be sent to the Commission under reference number COMP/39.595 — Continental/United/Lufthansa/Air Canada either by e-mail (COMP-GREFFE-ANTITRUST@ec.europa.eu), by fax (+32 22950128) or by post, to the following address:

21.12.2012   

EN

Official Journal of the European Union

C 396/24

Class 1.5.

Oils and fats (butter, margarine, oil, etc.)

Physical-chemical characteristics:

Organoleptic characteristics:

21.12.2012   

EN

Official Journal of the European Union

C 396/28

1.

Common Position 2008/369/CFSP (1) calls upon the Union to freeze the funds and economic resources of natural or legal persons, entities or bodies acting in violation of the arms embargo with regard to the Democratic Republic of the Congo, as referred to in the list drawn up pursuant to UNSR 1533(2004), 1596(2005), 1807(2008) and 1857(2008) to be updated regularly by the UN Committee established pursuant to UNSCR 1533(2004).

The list drawn up by this UN Committee comprises:

2.

The UN Sanctions Committee decided on 12 November 2012 to add one natural person and on 30 November 2012 to add two natural persons on the relevant list. The natural persons concerned may submit at any time a request to the UN Committee, together with any supporting documentation, for the decision to include them in the UN list referred to above, to be reconsidered. Such request should be sent to the following address:

See for information at: http://www.un.org/sc/committees/dfp.shtml

3.

Further to the UN decisions referred to at point 2, the Commission has adopted Regulation (EU) No 1251/2012 (2), which amends Annex I to Regulation (EC) No 1183/2005 imposing certain specific restrictive measures directed against persons acting in violation of the arms embargo with regard to the Democratic Republic of the Congo (3).

Therefore, the following measures of Regulation (EC) No 1183/2005 apply to the natural persons concerned:

4.

The natural persons added to Annex I to Council Regulation (EC) No 1183/2005, by means of Regulation (EU) No 1251/2012, and further to the UN decisions of 12 and 30 November 2012, may make their views on their listing known to the Commission. This communication should be sent to:

5.

The attention of the natural persons concerned is also drawn to the possibility of challenging Regulation (EU) No 1251/2012 before the General Court of the EU, in accordance with the conditions laid down in Article 263, paragraphs 4 and 6, of the Treaty on the Functioning of the European Union.

6.

Personal data of the natural persons concerned by the listings of Regulation (EU) No 1251/2012 will be handled in accordance with the rules of Regulation (EC) No 45/2001 on the protection of individuals with regard to the processing of personal data by the Community institutions and bodies and on the free movement of such data (4). Any request, e.g. for further information or in order to exercise the rights under Regulation (EC) No 45/2001 (e.g. access or rectification of personal data), should be sent to the Commission, under the same address mentioned under point 4 above.

7.

For good order, the attention of the natural persons listed in Annex I is drawn to the possibility of making an application to the competent authorities of the relevant Member State(s), as listed in Annex II to Regulation (EC) No 1183/2005, in order to obtain an authorisation to use frozen funds and economic resources for basic expenses or specific payments in accordance with Article 3 of that Regulation.

21.12.2012   

EN

Official Journal of the European Union

C 396/30